Clinical observation
[The efficacy of semax in the tretament of patients at different stages of ischemic stroke].
110 post-ischemic-stroke patients, rehabilitation comparisons
Reported findings. Reported BDNF/Barthel improvement
Nonresponse. Randomization and blinding not verified from abstract
Harms. Harms insufficiently reported
Limits. No transfer to other routes/formulations/indications; clinician review pending.
Preparation: Semax with background rehabilitation Route: Unknown in abstract
Read original source ↗Editorial review 2026-10-09. Clinician review pending.